title: Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
authors.forename: Malini
authors.initials: M
authors.lastname: Sharma
authors.forename: Lucie
authors.initials: L
authors.lastname: Buck
authors.forename: George
authors.initials: G
authors.lastname: Mastrogamvrakis
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Kontos
authors.forename: Adam
authors.initials: A
authors.lastname: Magos
authors.forename: Alex
authors.initials: A
authors.lastname: Taylor
mesh_terms: D003362:Cost-Benefit Analysis; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives*; D006801:Humans; D007044:Hysterectomy / Q000191:economics*; D007889:Leiomyoma / Q000601:surgery*; D017059:Models, Econometric; D009215:Myometrium / Q000601:surgery*; D011292:Premedication / Q000191:economics*; D014594:Uterine Neoplasms / Q000601:surgery*
chemical_list: D007987:Gonadotropin-Releasing Hormone